Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
Abstract Beta-adrenergic receptor blockers are used in patients with coronary artery disease (CAD) to reduce the harmful effects of excessive adrenergic activation on the heart. However, there is limited evidence regarding the benefit of beta-blockers in the context of contemporary management follow...
Guardado en:
Autores principales: | Pil Hyung Lee, Gyung-Min Park, Seungbong Han, Yong-Giun Kim, Jong-Young Lee, Jae-Hyung Roh, Jae-Hwan Lee, Young-Hak Kim, Seung-Whan Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5bd891b9d5694652b995f08a89f433cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Jangho Park, et al.
Publicado: (2021) -
Hospital-level variation in follow-up strategies after percutaneous coronary intervention, revealed in health claims data of Korea
por: Jae-Hyung Roh, et al.
Publicado: (2021) -
Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention.
por: Zoya Gurm, et al.
Publicado: (2021) -
Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention
por: Haseong Chang, et al.
Publicado: (2021) -
Association between inter-leg blood pressure difference and cardiovascular outcome in patients undergoing percutaneous coronary intervention.
por: Inki Moon, et al.
Publicado: (2021)